| UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis (NCT00638469) | Medical University of Graz | 2008-03-01 |
| Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies (NCT00688519) | Stiefel, a GSK Company | 2008-03-01 |
| A Phase I Study to Assess Novel Cream in a Psoriasis Plaque Test (NCT00763204) | Pfizer | 2008-02-29 |
| Granulocytapheresis in Psoriasis (NCT00714272) | EXcorLab GmbH | 2008-02-18 |
| Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy (NCT00566722) | Abbott | 2008-01-01 |
| PsoBest - The German Psoriasis Registry (NCT01848028) | Universitätsklinikum Hamburg-Eppendorf | 2008-01-01 |
| Study in Patients With Mild to Moderate Psoriasis (NCT01451346) | Alimentary Health Ltd | 2008-01-01 |
| Prevalence of Psoriasis Alba in Psoriatic Patients (NCT00835315) | Hadassah Medical Organization | 2008-01-01 |
| Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827 (NCT00867100) | Bausch Health Americas, Inc. | 2007-12-01 |
| Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (NCT00686686) | Merck Sharp & Dohme LLC | 2007-12-01 |
| A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test (NCT00762658) | Pfizer | 2007-11-30 |
| Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam (NCT00842153) | Stiefel, a GSK Company | 2007-11-01 |
| Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test (NCT00578370) | ISDIN | 2007-11-01 |
| A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) (NCT00686595) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy (NCT00581555) | Pfizer | 2007-10-01 |
| Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047) (NCT00749398) | Merck Sharp & Dohme LLC | 2007-09-01 |
| A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis (NCT00513370) | Abbott | 2007-09-01 |
| Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (NCT00482170) | Pfizer | 2007-09-01 |
| Can We Miss Pigmented Lesions in Psoriasis Patients? (NCT01053819) | University of Alabama at Birmingham | 2007-09-01 |
| A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis (NCT00399906) | Bristol-Myers Squibb | 2007-08-01 |
| Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis (NCT00830817) | Welichem Biotech Inc. | 2007-07-01 |
| A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. (NCT00504270) | Hoffmann-La Roche | 2007-07-01 |
| PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept (NCT00527072) | Centocor Ortho Biotech Services, L.L.C. | 2007-07-01 |
| Psoriasis Longitudinal Assessment and Registry (NCT00508547) | Janssen Scientific Affairs, LLC | 2007-06-21 |
| A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009) (NCT00684593) | Merck Sharp & Dohme LLC | 2007-06-01 |
| STA-21 Topical Efficacy on Psoriasis (NCT01047943) | Kochi University | 2007-06-01 |
| Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy (NCT00537212) | Bagel, Jerry, M.D. | 2007-06-01 |
| The Effectiveness of Lower Cyclosporine Doses for Psoriasis (NCT00377325) | University of Rochester | 2007-06-01 |
| A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis (NCT00820950) | Incyte Corporation | 2007-05-31 |
| Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis (NCT00477191) | Massachusetts General Hospital | 2007-05-01 |
| An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants (NCT00760669) | Janssen Korea, Ltd., Korea | 2007-05-01 |
| Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet (NCT00585650) | University of California, Irvine | 2007-05-01 |
| Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis (NCT00470392) | VA Office of Research and Development | 2007-05-01 |
| Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients (NCT01539915) | Novartis Pharmaceuticals | 2007-04-01 |
| Surveillance of Humira Injection in Korean Patients (NCT01083121) | AbbVie (prior sponsor, Abbott) | 2007-04-01 |
| Centocor Microarray Study of Patients (NCT00462072) | University of Rochester | 2007-03-01 |
| An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis (NCT00454584) | Centocor, Inc. | 2007-03-01 |
| AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects (NCT00443326) | Amgen | 2007-03-01 |
| A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy (NCT02193919) | Bagel, Jerry, M.D. | 2007-03-01 |
| A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis. (NCT00437619) | Hoffmann-La Roche | 2007-02-01 |
| Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy (NCT00368654) | University of California, Davis | 2007-01-01 |
| T Cell Repertoire Analysis of Immune Mediated Skin Diseases (NCT00368784) | University of California, Davis | 2007-01-01 |
| Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications (NCT00427609) | University of Tennessee | 2007-01-01 |
| Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis (NCT00395941) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2006-12-01 |
| Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients (NCT00408187) | Aurinia Pharmaceuticals Inc. | 2006-12-01 |
| Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. (NCT00417820) | Novartis | 2006-11-01 |
| Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900) (NCT00725452) | Merck Sharp & Dohme LLC | 2006-10-01 |
| Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis (NCT00384098) | OPKO Health, Inc. | 2006-09-01 |
| Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis (NCT01229085) | Azidus Brasil | 2006-09-01 |
| Molecular and Cellular Characterization of Spongiotic Dermatitis (NCT00371163) | University of California, Davis | 2006-09-01 |
| Etanercept Plus UVB-311nm Phototherapy in Psoriasis (NCT00550030) | Medical University of Graz | 2006-08-01 |
| Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis (NCT00372580) | National Taiwan University Hospital | 2006-08-01 |
| Fluphenazine Decanoate for Psoriasis (NCT00356200) | Tufts Medical Center | 2006-07-01 |
| Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin (NCT00697034) | Wake Forest University | 2006-06-01 |
| A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) (NCT00687401) | Merck Sharp & Dohme LLC | 2006-06-01 |
| Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis (NCT00333034) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-06-01 |
| Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis (NCT00333411) | Boehringer Ingelheim | 2006-06-01 |
| Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis (NCT00716144) | Stiefel, a GSK Company | 2006-06-01 |
| A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528) (NCT00687362) | Merck Sharp & Dohme LLC | 2006-05-30 |
| Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271, NCT00251641] (P04563) (NCT00358670) | Merck Sharp & Dohme LLC | 2006-05-01 |
| A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent (NCT00336973) | Genentech, Inc. | 2006-05-01 |
| Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis (NCT00606450) | Amgen | 2006-04-01 |
| Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis (NCT00329303) | UCB Pharma | 2006-04-01 |
| Adalimumab in Adult Japanese Subjects With Psoriasis (NCT00647400) | Abbott | 2006-04-01 |
| A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet (NCT00312026) | Genentech, Inc. | 2006-03-30 |
| Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis (NCT00332332) | Amgen | 2006-03-01 |
| A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam (NCT00436540) | Galderma R&D | 2006-03-01 |
| Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (NCT00727298) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis (NCT00437216) | Galderma R&D | 2006-02-01 |
| Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva) (NCT00602823) | National Taiwan University Hospital | 2006-02-01 |
| Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept (NCT00581165) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-02-01 |
| A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis (NCT00293917) | Astellas Pharma Inc | 2006-01-01 |
| Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists (NCT00293722) | Pfizer | 2006-01-01 |
| Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists (NCT00293709) | Pfizer | 2006-01-01 |
| Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis (NCT00279162) | LEO Pharma | 2005-12-01 |
| A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis (NCT00267969) | Centocor Research & Development, Inc. | 2005-12-01 |
| Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00338754) | Abbott | 2005-11-01 |
| Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris (NCT00235625) | University of Pennsylvania | 2005-10-01 |
| Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 (NCT00358384) | GlaxoSmithKline | 2005-09-26 |
| A 36-Week Extension to Protocol ISA04-03 (NCT00258713) | Aurinia Pharmaceuticals Inc. | 2005-09-01 |
| Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis (NCT00143819) | University of Medicine and Dentistry of New Jersey | 2005-09-01 |
| Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis (NCT00147329) | Merrimack Pharmaceuticals | 2005-09-01 |
| A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis (NCT01045577) | AB Science | 2005-09-01 |
| Acitretin and Etanercept in Psoriasis (NCT00156247) | University of Medicine and Dentistry of New Jersey | 2005-09-01 |
| The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED) (NCT00251641) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Study of a New Dressing for Use With Topical Medications (NCT00234728) | Teikoku Pharma USA, Inc. | 2005-09-01 |
| Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED) (NCT00254982) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis (NCT00407979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00235820) | Abbott | 2005-07-01 |
| Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris (NCT00365625) | Johann Wolfgang Goethe University Hospital | 2005-07-01 |
| Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis (NCT00301002) | The Guenther Dermatology Research Centre | 2005-06-01 |
| A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis (NCT00307437) | Centocor Research & Development, Inc. | 2005-05-01 |
| Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis (NCT00161655) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-04-01 |
| Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases. (NCT00217009) | Mayo Clinic | 2005-03-01 |
| Etanercept With Tacrolimus for Psoriasis (NCT00134394) | University of Medicine and Dentistry of New Jersey | 2005-02-01 |
| An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW) (NCT00097240) | Genentech, Inc. | 2005-01-01 |
| Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis (NCT00604682) | Amgen | 2005-01-01 |
| Evaluation of the Efficacy of Acitretin Therapy for Nail Psoriasis (NCT00723437) | Istituti Fisioterapici Ospitalieri | 2005-01-01 |
| A Study of Efalizumab in Participants With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic Therapies (NCT00249808) | Merck KGaA, Darmstadt, Germany | 2004-12-13 |
| Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis (NCT00195507) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-12-01 |